Sign Up to Receive the Latest Trading Tips and News from Prosper

    February 26, 2019

    The Clock Is Ticking On Karyopharm Therapeutics

    Karyopharm Therapeutics Inc (KPTI) shares were down today as the company awaits the FDA’s decision on its Selinexor new drug application (“NDA”). The company’s stock dropped sharply on Friday, losing around 50% of its value due to FDA notes being leaked, in which the FDA voiced skepticism as to the benefit of approving the new […]

    Read Article
    February 22, 2019

    Darker Days Ahead For Karyopharm Therapeutics?

    Karyopharm Therapeutics (KPTI) shares were down sharply today after negative comments from the FDA regarding their drug application for Selinexor. The FDA noted that it doesn’t see the benefit of the drug with respect to its potential risks. This report was to be released later this month, but apparently was leaked today, causing the sharp […]

    Read Article